11.16.23
Many health care stakeholders have long relied on the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) guidance regarding an effective compliance program when developing their own compliance programs, especially when contracts and less prescriptive federal and ...
10.31.23
The Center for Medicare and Medicaid Innovation (CMMI) has provided new updates on CMS’ planned initiatives to address prescription drug costs in a blog post from Director Liz Fowler.
09.20.23
In 2020, Medicaid spent $220.8 billion on hospital care. Hospital care accounted for 33% of Medicaid spending.
05.17.23
On Thursday, April 27, the Centers for Medicare & Medicaid Services (CMS) released two highly anticipated proposed rules.
03.01.23
On February 24, the Drug Enforcement Administration, in consultation with the Department of Health and Human Services, issued two proposed rules that address the prescribing of controlled substances based solely on a telemedicine encounter.
01.03.23
On November 28, the Department of Health and Human Services released a proposed rule that seeks to better align the Confidentiality of Substance Use Disorder Patient Records regulations under 42 CFR part 2 with the regulatory requirements under the Health Insurance Portability and ...
12.12.22
On December 1, the Senate Finance Committee released the fifth and final discussion draft of the Committee’s bipartisan mental health initiative.
11.01.22
The 340B Drug Pricing Program, which was enacted in 1992 by Section 340B of the federal Public Health Services Act, requires pharmaceutical manufacturers that participate in the Medicaid program to provide covered outpatient drugs at significantly reduced prices to certain health care providers and ...
09.28.22
On September 23, the Centers for Medicare & Medicaid Services (CMS) reopened the comment period for a November 2020 interim final rule titled “Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency.”
09.07.22
On August 19, the Biden Administration released a final rule on the No Surprises Act that primarily addresses regulatory provisions invalidated by the United States District Court for the Eastern District of Texas regarding how reimbursement amounts for out-of-network providers will be calculated ...